These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25645432)

  • 1. A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study.
    Cailleux A; Vuillermet P; Basuyau JP; Ménard JF; Lefebvre H; Kuhn JM; Prévost G
    Clin Endocrinol (Oxf); 2015 May; 82(5):663-9. PubMed ID: 25645432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism.
    Titon I; Cailleux-Bounacer A; Basuyau JP; Lefebvre H; Savouré A; Kuhn JM
    Eur J Endocrinol; 2007 Sep; 157(3):351-7. PubMed ID: 17766719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
    Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
    Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy.
    Iglesias P; Ais G; González A; Tajada P; García Arévalo C; Fernández Pardo E; Díez JJ
    Am J Med Sci; 2008 Feb; 335(2):111-4. PubMed ID: 18277118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.
    Sharma AK; Masterson R; Holt SG; Tan SJ; Hughes PD; Chu M; Jayadeva P; Toussaint ND
    Nephrology (Carlton); 2016 Jan; 21(1):46-54. PubMed ID: 26072678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.
    Shoback DM; Bilezikian JP; Turner SA; McCary LC; Guo MD; Peacock M
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5644-9. PubMed ID: 14671147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
    Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
    Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
    Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.
    Peacock M; Bilezikian JP; Klassen PS; Guo MD; Turner SA; Shoback D
    J Clin Endocrinol Metab; 2005 Jan; 90(1):135-41. PubMed ID: 15522938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery].
    Arranz Martín A; Azcárate Villalón A; Luque Ramírez M; Santana Durán B; Marazuela Azpíroz M; Paniagua Ruiz A; Carraro R; Gómez Pan A
    Endocrinol Nutr; 2011 Jan; 58(1):24-31. PubMed ID: 21277266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinacalcet for the treatment of primary hyperparathyroidism.
    Sajid-Crockett S; Singer FR; Hershman JM
    Metabolism; 2008 Apr; 57(4):517-21. PubMed ID: 18328354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.
    Saponaro F; Faggiano A; Grimaldi F; Borretta G; Brandi ML; Minisola S; Frasoldati A; Papini E; Scillitani A; Banti C; Del Prete M; Vescini F; Gianotti L; Cavalli L; Romagnoli E; Colao A; Cetani F; Marcocci C
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):20-6. PubMed ID: 23228121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinacalcet (Sensipar) provides no measurable clinical benefits for patients with primary hyperparathyroidism and may accelerate bone loss with prolonged use.
    Norman J; Lopez J; Politz D
    Ann Surg Oncol; 2012 May; 19(5):1466-71. PubMed ID: 21922336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
    Silverberg SJ; Rubin MR; Faiman C; Peacock M; Shoback DM; Smallridge RC; Schwanauer LE; Olson KA; Klassen P; Bilezikian JP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3803-8. PubMed ID: 17666472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet effect on severe hyperparathyroidism.
    Al Saran K; Sabry A; Yehia A; Molhem A
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):867-71. PubMed ID: 20814122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
    Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
    J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism.
    Muñoz-Torres M; García-Martín A
    Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.